Skip to Content

Zipsor Approval History

  • FDA approved: Yes (First approved June 16th, 2009)
  • Brand name: Zipsor
  • Generic name: diclofenac potassium
  • Dosage form: Capsules
  • Company: Xanodyne Pharmaceuticals, Inc.
  • Treatment for: Pain

Zipsor is a rapid release diclofenac potassium formulation for the treatment of patients with mild to moderate acute pain.

Development History and FDA Approval Process for Zipsor

Jun 17, 2009Approval Xanodyne Receives Approval From the U.S. Food and Drug Administration for Zipsor (diclofenac potassium) Liquid Filled Capsules
Jul 22, 2008Xanodyne Receives Approvable Letter From the FDA for Zipsor Capsules

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.